Industry News
FDA Recommends Recall of Artificial Eye Ointment for Potential Bacterial Contamination
This warning is the second on top of a previous warning not to purchase or use EzriCare Artificial Tears or Delsam Pharma’s Artificial Tears due to potential bacterial contamination.
Agilent Gains Design Support from CRB for Manufacturing Facility Expansion
Agilent’s therapeutic nucleic acids facility gains architectural design support from CRB.
FDA Publishes New Product-Specific Guidelines for Generic Drug Development
Some noteworthy PSGs include dihydroergotamine mesylate nasal spray, glucagon nasal powder, afamelanotide subcutaneous implant, and triamcinolone acetonide injectable suspension.
FDA Announces BsUFA III Regulatory Science Program to Support Future Research
The intention of the FOA is to address diverse topics related to improving the efficiency of biosimilar product development and advancing the development of interchangeable products.
Bayer Names Bill Anderson as CEO
Bill Anderson, former CEO of Roche’s pharmaceutical division, will take over as CEO of Bayer on June 1, 2023.
Charles River Launches Novel IgY-based ELISA Kit
The kit is meant for use for the detection and quantitation of residual host cell protein.
Clinical Trial Diversity Continues to Face Challenges
After years of FDA issuing guidance documents and launching programs to encourage sponsors to seek broader representation in clinical trials, policy makers have added a “stick” to the process.
New Data from EMA’s Review of Medicines with Pseudoephedrine
Pseudoephedrine is an oral treatment that can be used alone or in combination with other medicines to treat nasal congestion resulting from a cold, flu, or allergy.
FDA Accepts Biologics License Application for Proposed Biosimilar Denosumab
The BLA includes a comprehensive analytical and clinical data package, including data from the Phase I/III ROSALIA study.
Biden Hits Drug Prices for Boosting Health Care Costs
Biden outlined a host of priorities for improving health care and building the economy during State of the Union address.
Pharmapack Europe Announces Winners of Pharmapack 2023 Awards
Pharmapack Europe has announced the winners of the 2023 Pharmapack Awards spanning five categories across two dedicated awards.
Recent Initiatives to Support Development of Medicines for Children
Clinicians, pediatric patients, regulators, and more are being considered to further strengthen focus on unmet medical needs.
Thermo Fisher Scientific Collaborates to Introduce Fully Automated Cell Line Automation Platform
Thermo Fisher and Celltrio are introducing a new automation platform to address critical scale-up challenges in biotherapeutics.
Astellas to Appoint New CEO and President
Naoki Okamura, Astellas’ current chief strategy officer, will take over the role from Kenji Yasukawa.
BioNTech Strengthens Manufacturing Capabilities with First In-house Plasmid DNA Manufacturing Facility
The new plasmid manufacturing facility aims to increase BioNTech’s autonomy and flexibility in manufacturing.
Thermo Fisher Scientific Announces Founding Sponsorship of Momentum Labs
Thermo Fisher’s sponsorship of Momentum Labs is intended to support biotech businesses in the greater Gainesville region.
FDA Food Center Reorg Puts Field Inspections in Limbo
A realignment of the Office of Regulatory Affairs would create a focus on “critical activities” for ensuring the safety of foods and other regulated products, including drugs, biologics, and medical devices.
Advantageous Positioning for Europe in Pharmaceutical Cannabis
The European bio/pharma industry’s high regulatory standards and GMP requirements are set to position the region as a frontrunner for pharmaceutical‑grade manufacturing of cannabis-based medicines.
Improving Gender Diversity
Although some headway is being made into more gender-diverse executive levels in pharma, much more work is still needed.
Bioequivalence for Immediate-Release Solid Oral Dosage Forms
Any deviations from the recommendations in this guideline may be acceptable if appropriate scientific justification is provided.
Gerresheimer Presents New Clinical Trial Kit at Pharmapack
Gerresheimer is presenting its new Clinical Trial Kit to accelerate drug development at Pharmapack in Paris.
FDA Resumes In-Person Meetings with Industry … Sort Of
FDA will restart in-person, face-to-face meetings with industry sponsors beginning Feb. 13, 2023, after a shift to all-virtual meetings during the pandemic.
Pharmapack Experts Predict Increased Packaging Consolidations in 2023
Pharmapack Europe experts expect smaller and medium European packaging companies to grow or be acquired.
FDA Seeks to Simplify COVID-19 Vaccination Program
FDA plans to authorize a common bivalent shot that targets both the original COVID-19 strain and Omicron subvariants.
FDA Releases Research Roadmap for Biosimilars Pilot Program
The BsUFA facilitates the development of safe and effective biosimilars and interchangeable biosimilars for patients by supporting FDA review of biosimilar submissions.
Amgen, Illumina, and Nashville Biosciences Announce Genome Sequencing Agreement
deCODE genetics, a subsidiary of Amgen, will whole-genome sequence 35,000 African-American samples provided by Illumina and Nashville Biosciences.
USPTO Issues Notice of Allowance for Zika Vaccine Patent
The United States Patent and Trademark Office issued a Notice of Allowance for Zika vaccine patent to GeoVax.
FDA Issues Guidance on Development of Drugs for Monkeypox
The guidance is intended to provide nonclinical, virology, and clinical considerations for mpox drug development programs, targeting on recommendations to support initiation of clinical trials.
Providing a Snapshot of the Industry
CRB’s latest industry report includes an expanded audience to include many European countries, which has provided some interesting insights.
Vetter Wins Gold in EcoVadis Ranking
Vetter significantly increases its sustainability ranking by achieving gold status in EcoVadis ranking.